The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

China to try GSK-linked investigator in secret - family friends

Thu, 03rd Jul 2014 06:42

SHANGHAI, July 3 (Reuters) - The trial in China of a Britishcorporate investigator and his American wife and businesspartner arrested a year ago after they did work forGlaxoSmithKline PLC will be closed to the public, twofamily friends with knowledge of the matter told ReutersThursday.

The detention of Peter Humphrey and Yu Yingzeng has sentshockwaves through the foreign business community. For years,the community has relied on investigative firms such as thecouple's Shanghai-based company ChinaWhys to better understandthe Chinese business environment.

In April 2013, GSK employed ChinaWhys to investigate anex-employee suspected of sending anonymous emails, including thecirculation of an intimate video of former GSK China head MarkReilly with his girlfriend, as well as emails containingallegations of widespread bribery at the British drugmaker.

Three months later, authorities detained Humphrey and Yu forillegally buying and selling private information. Chineseauthorities have not openly made a link between GSK and the caseagainst ChinaWhys.

The couple were subsequently arrested, which typically meansthe police believe they have enough evidence for the case to bebrought to trial. They are being held in Shanghai, but it is notknown in which court they will be tried.

U.S. consular officials had been informed on Wednesday whenvisiting Yu that they would not be able to attend the trial, andthat the decision to keep the trial closed had been made on thegrounds of privacy, according to the couple's family friends,who declined to be identified because of the apparentsensitivity of the case.

The trial date has also been pushed back a week to Aug. 7from July 29, the people said.

The U.S. and British consulates declined to comment.

CLOSED TRIALS

In China, court cases involving state secrets or nationalsecurity are regularly closed to the public. However, thecouple's son said in a statement this case involved neither.

"I am very worried that family and consular officials arenot allowed to attend my parents' trial. This does not involvestate secrets. This does not involve national security," HarveyHumphrey, 19, said in the statement to media.

"I am surprised at this decision since China wants topromote openness and the rule of law and I hope that they willlet me in."

One of the family friends said the defendants' lawyers hadbeen required by the prosecutor to sign non-disclosureagreements.

"The client doesn't even know what's going on," the personsaid. The reason for the non-disclosure agreements was notclear, but underscore the sensitivity of the case.

Officials contacted by telephone at the Shanghaiprocuratorate and municipal intermediate courts said they didnot know about the case. There was no listing of the trial onAug. 7 or July 29 on an online docket for all of Shanghai'scourts.

China's foreign ministry did not immediately respond tofaxed requests for comment.

Chinese authorities last month charged Reilly and othercolleagues with corruption, after a government investigationfound the firm made billions of yuan from elaborate schemes tobribe doctors.

GSK's tangled web of problems in China were highlighted in alengthy draft report seen by Reuters. The report had beenprepared by ChinaWhys and presented to GSK on June 6 Last year.

The report into the origin of the video and emails did notreach a conclusion as to who was behind the actions.

Humphrey previously worked for Reuters in Asia, EasternEurope and the Balkans, according to the website of ChinaWhys. (Reporting by John Ruwitch; Editing by Ryan Woo)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.